Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of the Nanodropper Device on Pupillary Dilation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants under the age of 18 years old~Exclusion Criteria:~* Participants 18 years and older~* Pupillary or anterior segment abnormality~* Participants with pre-existing health conditions that would prevent pupillary dilation.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Pediatric Participant's Eyes Using Standard Pupilary Dilation (Type: ACTIVE_COMPARATOR): Consenting pediatric participants will undergo standard pupillary dilation in one eye.
- Pediatric Participant's Eyes using Nanodropper attachment (Type: EXPERIMENTAL): Consenting pediatric participants will undergo pupillary dilation in the second eye using the Nanodropper attachment.

Based on this trial design, predict the completion outcome and termination type (if applicable).